SYRACUSE, NY / ACCESS Newswire / May 12, 2026 / Repair Biotechnologies, Inc., a biotechnology company developing first-in-class therapies capable of rapidly regressing atherosclerotic plaque, today ...
SYRACUSE, NY / ACCESS Newswire / May 12, 2026 / Repair Biotechnologies, Inc., a biotechnology company developing first-in-class therapies capable of rapidly regressing atherosclerotic plaque, today an ...
A landmark study led by researchers at Keck Medicine of USC, recently published in the Journal of Vascular Surgery, indicates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results